Santiago Vázquez - Concepedia

Author

Santiago Vázquez

Also Known As

S Vázquez, S. B. Vázquez, S. VAZQUEZ, S. Vazquez, S. Vázquez, S. Vázquez, Santiago Vazquez, Santiago Vázquez, Sara López Vázquez, Vazquez, Santiago

220

Publications

2.9K

Citations

H-Index

106

Concepts

All Affiliations

Universitat de Barcelona Rega Institute for Medical Research KU Leuven Universitat Rovira i Virgili Center for Research in Molecular Medicine and Chronic Diseases

About

Santiago Vázquez is an author at Universitat de Barcelona specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	1.2K
2	Engineering	13	13	324
3	Natural Sciences	9	9	373
4	Health Sciences	2	2	44
5	Arts	1	1	26

Santiago Vázquez

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Novel Protein Modification by Kynurenine in Human Lenses Santiago Vázquez, J. Andrew Aquilina, Margaret M. Sheil, Journal of Biological Chemistry Ocular DiseaseHuman LensBiochemistryOphthalmologyNovel Protein Modification	2002	136
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease Mohammad Zarei, Emma Barroso, Xavier Palomer, Molecular Metabolism	2017	109
Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions Santiago Vázquez, Brett Garner, Margaret M. Sheil, Free Radical Research	2000	91
Chemistry of pyramidalized alkenes Santiago Vázquez, Pelayo Camps Tetrahedron Novel OrganocatalystsAlkene MetathesisOrganic ChemistryOrganometallic CatalysisChemistry	2005	89
Identification of Glutathionyl-3-hydroxykynurenine Glucoside as a Novel Fluorophore Associated with Aging of the Human Lens Brett Garner, Santiago Vázquez, Renate Griffith, Journal of Biological Chemistry Pharmaceutical ScienceGlutathionyl-3-hydroxykynurenine GlucosideHuman LensOcular DiseaseOphthalmology	1999	78
Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model Christian Griñán‐Ferré, Laura Marsal‐García, Aina Bellver‐Sanchís, Aging	2019	78
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease Christian Griñán‐Ferré, Sandra Codony, Eugènia Pujol, Neurotherapeutics Soluble Epoxide HydrolaseAlzheimer's DiseaseBiochemistryMedicineDementia	2020	78
Exploring the Size Limit of Templates for Inhibitors of the M2 Ion Channel of Influenza A Virus Maria del Mar Sanchez Duque, Chunlong Ma, Eva Torres, Journal of Medicinal Chemistry	2011	76
Easily Accessible Polycyclic Amines that Inhibit the Wild-Type and Amantadine-Resistant Mutants of the M2 Channel of Influenza A Virus Matías Rey-Carrizo, Marta Barniol‐Xicota, Chunlong Ma, Journal of Medicinal Chemistry Antiviral CompoundBiochemistrySynthetic VirologyMedicineAntiviral Drug Development	2014	64
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice Júlia Companys‐Alemany, Andreea L. Turcu, Aina Bellver‐Sanchís, Pharmaceutics	2020	60

Page 1